Case Reports
doi: 10.1002/ajh.20090.
Desferrioxamine related maculopathy: a case report
Affiliations
- PMID: 15282675
- DOI: 10.1002/ajh.20090
Item in Clipboard
Case Reports
Desferrioxamine related maculopathy: a case report
Am J Hematol.
2004 Aug.
Free article
Abstract
Desferrioxamine is used for the treatment of chronic iron overload, acute iron poisoning, and certain anaemias. Ocular toxicity secondary to prolonged treatment with desferrioxamine may result in night blindness, visual field constriction, cataract, pigmentary retinopathy and optic neuropathy. To avoid such complications an ophthalmic screening has been suggested for patients taking desferrioxamine. We report an 81-year-old patient who developed irreversible ocular toxicity despite undergoing ophthalmic screening.
Copyright 2004 Wiley-Liss, Inc.
Similar articles
-
Diagnostic and therapeutic challenges.Retina. 2007 Jun;27(5):642-7. doi: 10.1097/IAE.0b013e31804b4003. Retina. 2007. PMID: 17558329 No abstract available.
-
Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population.Retina. 2008 Jun;28(6):894-9. doi: 10.1097/IAE.0b013e3181679f67. Retina. 2008. PMID: 18536609
-
[Bull's-Eye Maculopathy with Deferoxamine Treatment].Klin Monbl Augenheilkd. 2004 Mar;221(3):204-9. doi: 10.1055/s-2004-812850. Klin Monbl Augenheilkd. 2004. PMID: 15052528 German.
-
Retinal abnormalities in β-thalassemia major.Surv Ophthalmol. 2016 Jan-Feb;61(1):33-50. doi: 10.1016/j.survophthal.2015.08.005. Epub 2015 Aug 29. Surv Ophthalmol. 2016. PMID: 26325202 Free PMC article. Review.
-
[Retinal pigment epithelium--desferal].Bull Soc Belge Ophtalmol. 2007;(304):59-66. Bull Soc Belge Ophtalmol. 2007. PMID: 17718228 Review. French.
Cited by
-
Pattern dystrophies in patients treated with deferoxamine: report of two cases and review of the literature.BMC Ophthalmol. 2018 Sep 12;18(1):246. doi: 10.1186/s12886-018-0911-2. BMC Ophthalmol. 2018. PMID: 30208862 Free PMC article.
-
Oral nucleic acid therapy using multicompartmental delivery systems.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Mar;10(2):10.1002/wnan.1478. doi: 10.1002/wnan.1478. Epub 2017 May 24. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018. PMID: 28544521 Free PMC article. Review.
-
Neuroprotective Effects of Transferrin in Experimental Glaucoma Models.Int J Mol Sci. 2022 Oct 22;23(21):12753. doi: 10.3390/ijms232112753. Int J Mol Sci. 2022. PMID: 36361544 Free PMC article.
-
Desferrioxamine-related ocular toxicity: a case report.Indian J Ophthalmol. 2012 Jul;60(4):315-7. doi: 10.4103/0301-4738.98714. Indian J Ophthalmol. 2012. PMID: 22824603 Free PMC article.
-
Ocular abnormalities in beta thalassemia patients: prevalence, impact, and management strategies.Int Ophthalmol. 2020 Feb;40(2):511-527. doi: 10.1007/s10792-019-01189-3. Epub 2019 Oct 10. Int Ophthalmol. 2020. PMID: 31602527 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
